Bayer Alleges Patent Infringement Over Yaz

Law360, New York (November 6, 2007, 12:00 AM EST) -- Bayer AG has filed a lawsuit against Watson Laboratories Inc., alleging patent infringement related to the oral contraceptive Yaz, Bayer revealed in an earnings statement Tuesday.

In the complaint filed Monday in the U.S. District Court for the District of Nevada, Bayer said Watson has submitted to the U.S. Food and Drug Administration an Abbreviated New Drug Application seeking approval to make a generic version of the Yaz tablet. Bayer said it was notified about the ANDA last month.

Yaz, a combination of drospirenone and ethinyl...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.